Type II transmembrane serine proteases 4 (TMPRSS4) promotes proliferation, invasion and epithelial–mesenchymal transition in endometrial carcinoma cells (HEC1A and Ishikawa) via activation of MAPK and AKT
Endometrial cancer is the most common gynecological cancer in the developed countries. Type II transmembrane serine proteases 4 (TMPRSS4) is a newly discovered transmembrane protein, which may be related to the invasion, metastasis of the tumor and the poor prognosis. This study aims to investigate...
Main Authors: | Huan Xiao, Zhian Zhang, Dan Peng, Chunqing Wei, Benling Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-07-01
|
Series: | Animal Cells and Systems |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19768354.2021.1944311 |
Similar Items
-
Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
by: Rosalinda Posadas-Sánchez, et al.
Published: (2022-09-01) -
RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia
by: Teresa Maria Seccia, et al.
Published: (2023-10-01) -
COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs.
by: Jerzy Jankun
Published: (2020-04-01) -
TMPRSS2 and MSPL Facilitate Trypsin-Independent Porcine Epidemic Diarrhea Virus Replication in Vero Cells
by: Wen Shi, et al.
Published: (2017-05-01) -
Blocking serine protease (TMPRSS2) by Bromhexine; looking at potential treatment to prevent COVID-19 infection
by: Ramin Tolouian, et al.
Published: (2020-07-01)